127 related articles for article (PubMed ID: 8014453)
1. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes.
Ackerman Z; Wands JR; Gazitt Y; Brechot C; Kew MC; Shouval D
J Hepatol; 1994 Mar; 20(3):398-404. PubMed ID: 8014453
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in HBsAg-positive and HBsAg-negative chronic liver diseases.
Pastore G; Schena FP; Angarano G; Monno L; Santantonio T; Pertosa G; Schiraldi O
Ric Clin Lab; 1984; 14(1):29-35. PubMed ID: 6427879
[TBL] [Abstract][Full Text] [Related]
3. Chronic liver disease: the detection and characterization of circulating immune complexes.
Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients.
Brown SE; Howard CR; Steward MW; Ajdukiewicz AB; Whittle HC
Clin Exp Immunol; 1984 Feb; 55(2):355-9. PubMed ID: 6199140
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan.
Lai MY; Chen PJ; Yang PM; Sheu JC; Sung JL; Chen DS
Hepatology; 1990 Sep; 12(3 Pt 1):575-81. PubMed ID: 2169454
[TBL] [Abstract][Full Text] [Related]
6. Detection and characterization of circulating immune complexes during acute exacerbation of chronic viral hepatitis.
Araki K; Nagashima H; Tsuji T
Clin Exp Immunol; 1982 Mar; 47(3):520-6. PubMed ID: 6282506
[TBL] [Abstract][Full Text] [Related]
7. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
8. Comparison between polyclonal and first and second generation monoclonal radioimmunoassays in the detection of hepatitis B surface antigen in patients with hepatocellular carcinoma.
Kew MC; Fujita Y; Takahashi H; Coppins A; Wands JR
Hepatology; 1986; 6(4):636-9. PubMed ID: 3015759
[TBL] [Abstract][Full Text] [Related]
9. Immunological aspects of cryoprecipitates from the sera of chronic HBsAg carriers.
Tiku ML; Beutner KR; Ogra PL
Clin Exp Immunol; 1979 Apr; 36(1):54-62. PubMed ID: 466862
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatitis B and C viruses in liver tissue with hepatocellular carcinoma.
Diamantis ID; McGandy CE; Chen TJ; Liaw YF; Gudat F; Bianchi L
J Hepatol; 1994 Mar; 20(3):405-9. PubMed ID: 8014454
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.
Stroffolini T; Chiaramonte M; Tiribelli C; Villa E; Simonetti RG; Rapicetta M; Stazi MA; Bertin T; Crocè SL; Trande P
J Hepatol; 1992 Nov; 16(3):360-3. PubMed ID: 1336785
[TBL] [Abstract][Full Text] [Related]
15. Antigen-specific detection of HBsAg-containing immune-complexes in sera from chronic active hepatitis patients with hepatitis B virus persistent infection by enzyme-immunoassay (EIA).
Tsuji T; Araki K; Tsuchiya M; Nagashima H; Naito K
Gastroenterol Jpn; 1980; 15(6):606-8. PubMed ID: 6161054
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of HBsAg as the antigen component in circulating immune complexes detected by peg-solid phase test.
Sansonno DE; Detomaso P; Primavera MV; Papanice MA; Donnaloia R; Manghisi OG
J Virol Methods; 1986 Sep; 14(2):141-51. PubMed ID: 3771731
[TBL] [Abstract][Full Text] [Related]
18. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
[TBL] [Abstract][Full Text] [Related]
19. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
Tsai JF; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Br J Cancer; 1996 Jun; 73(12):1498-502. PubMed ID: 8664119
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B disease in dialysis and transplant patients. Further epidemiologic and serologic studies.
Harnett JD; Zeldis JB; Parfrey PS; Kennedy M; Sircar R; Steinmann TI; Guttmann RD
Transplantation; 1987 Sep; 44(3):369-76. PubMed ID: 2820093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
